A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer
NCT06939595
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
606
Enrollment
INDUSTRY
Sponsor class
Conditions
Non Squamous Non Small Cell Lung Cancer
Interventions
DRUG:
CT-P51
DRUG:
EU-approved Keytruda
Sponsor
Celltrion